Global Recombinant Human Coagulation Factor IX Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Recombinant Human Coagulation Factor IX market size was valued at US$ 580 million in 2024 and is forecast to a readjusted size of USD 743 million by 2031 with a CAGR of 3.5% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Recombinant human coagulation factor IX is a drug produced by genetic recombination technology, mainly used to treat hemophilia B (i.e. congenital coagulation factor IX deficiency). Its function is to supplement the coagulation factor IX that is lacking in the patient's body to help control and prevent bleeding. The drug is a colorless and clear solution after reconstitution. It is suitable for daily bleeding management and perioperative management of hemophilia B patients, but is not suitable for the treatment of other types of coagulation factor deficiency or conditions related to the anticoagulant effect of coumarin.
This report is a detailed and comprehensive analysis for global Recombinant Human Coagulation Factor IX market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Human Coagulation Factor IX market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Coagulation Factor IX market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Recombinant Human Coagulation Factor IX product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Coagulation Factor IX, with price, sales quantity, revenue, and global market share of Recombinant Human Coagulation Factor IX from 2020 to 2025.
Chapter 3, the Recombinant Human Coagulation Factor IX competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Coagulation Factor IX breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Human Coagulation Factor IX market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Coagulation Factor IX.
Chapter 14 and 15, to describe Recombinant Human Coagulation Factor IX sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Recombinant human coagulation factor IX is a drug produced by genetic recombination technology, mainly used to treat hemophilia B (i.e. congenital coagulation factor IX deficiency). Its function is to supplement the coagulation factor IX that is lacking in the patient's body to help control and prevent bleeding. The drug is a colorless and clear solution after reconstitution. It is suitable for daily bleeding management and perioperative management of hemophilia B patients, but is not suitable for the treatment of other types of coagulation factor deficiency or conditions related to the anticoagulant effect of coumarin.
This report is a detailed and comprehensive analysis for global Recombinant Human Coagulation Factor IX market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Human Coagulation Factor IX market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Recombinant Human Coagulation Factor IX market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Recombinant Human Coagulation Factor IX
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Coagulation Factor IX market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 250 IU/Bottle
- 500 IU/Bottle
- 1000 IU/Bottle
- 2000 IU/Bottle
- Adult Patients
- Child Patients
- Grifols
- Biogen
- Octapharma
- Baxter
- Cusabio
- Sanofi
- Cayman
- NovoPro Bioscience
- Sino Biological
- Bio-Techne
- IDELVION
- Hualan Bio
- Shuyang
- ChinaBiologic
- Diagbio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Recombinant Human Coagulation Factor IX product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Coagulation Factor IX, with price, sales quantity, revenue, and global market share of Recombinant Human Coagulation Factor IX from 2020 to 2025.
Chapter 3, the Recombinant Human Coagulation Factor IX competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Coagulation Factor IX breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Human Coagulation Factor IX market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Coagulation Factor IX.
Chapter 14 and 15, to describe Recombinant Human Coagulation Factor IX sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Human Coagulation Factor IX Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 250 IU/Bottle
1.3.3 500 IU/Bottle
1.3.4 1000 IU/Bottle
1.3.5 2000 IU/Bottle
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Human Coagulation Factor IX Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Adult Patients
1.4.3 Child Patients
1.5 Global Recombinant Human Coagulation Factor IX Market Size & Forecast
1.5.1 Global Recombinant Human Coagulation Factor IX Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Recombinant Human Coagulation Factor IX Sales Quantity (2020-2031)
1.5.3 Global Recombinant Human Coagulation Factor IX Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Recombinant Human Coagulation Factor IX Product and Services
2.1.4 Grifols Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Grifols Recent Developments/Updates
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Recombinant Human Coagulation Factor IX Product and Services
2.2.4 Biogen Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Biogen Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Recombinant Human Coagulation Factor IX Product and Services
2.3.4 Octapharma Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Octapharma Recent Developments/Updates
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Recombinant Human Coagulation Factor IX Product and Services
2.4.4 Baxter Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Baxter Recent Developments/Updates
2.5 Cusabio
2.5.1 Cusabio Details
2.5.2 Cusabio Major Business
2.5.3 Cusabio Recombinant Human Coagulation Factor IX Product and Services
2.5.4 Cusabio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Cusabio Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Recombinant Human Coagulation Factor IX Product and Services
2.6.4 Sanofi Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanofi Recent Developments/Updates
2.7 Cayman
2.7.1 Cayman Details
2.7.2 Cayman Major Business
2.7.3 Cayman Recombinant Human Coagulation Factor IX Product and Services
2.7.4 Cayman Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cayman Recent Developments/Updates
2.8 NovoPro Bioscience
2.8.1 NovoPro Bioscience Details
2.8.2 NovoPro Bioscience Major Business
2.8.3 NovoPro Bioscience Recombinant Human Coagulation Factor IX Product and Services
2.8.4 NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 NovoPro Bioscience Recent Developments/Updates
2.9 Sino Biological
2.9.1 Sino Biological Details
2.9.2 Sino Biological Major Business
2.9.3 Sino Biological Recombinant Human Coagulation Factor IX Product and Services
2.9.4 Sino Biological Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sino Biological Recent Developments/Updates
2.10 Bio-Techne
2.10.1 Bio-Techne Details
2.10.2 Bio-Techne Major Business
2.10.3 Bio-Techne Recombinant Human Coagulation Factor IX Product and Services
2.10.4 Bio-Techne Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bio-Techne Recent Developments/Updates
2.11 IDELVION
2.11.1 IDELVION Details
2.11.2 IDELVION Major Business
2.11.3 IDELVION Recombinant Human Coagulation Factor IX Product and Services
2.11.4 IDELVION Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 IDELVION Recent Developments/Updates
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Recombinant Human Coagulation Factor IX Product and Services
2.12.4 Hualan Bio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Hualan Bio Recent Developments/Updates
2.13 Shuyang
2.13.1 Shuyang Details
2.13.2 Shuyang Major Business
2.13.3 Shuyang Recombinant Human Coagulation Factor IX Product and Services
2.13.4 Shuyang Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuyang Recent Developments/Updates
2.14 ChinaBiologic
2.14.1 ChinaBiologic Details
2.14.2 ChinaBiologic Major Business
2.14.3 ChinaBiologic Recombinant Human Coagulation Factor IX Product and Services
2.14.4 ChinaBiologic Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 ChinaBiologic Recent Developments/Updates
2.15 Diagbio
2.15.1 Diagbio Details
2.15.2 Diagbio Major Business
2.15.3 Diagbio Recombinant Human Coagulation Factor IX Product and Services
2.15.4 Diagbio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Diagbio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT HUMAN COAGULATION FACTOR IX BY MANUFACTURER
3.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Manufacturer (2020-2025)
3.2 Global Recombinant Human Coagulation Factor IX Revenue by Manufacturer (2020-2025)
3.3 Global Recombinant Human Coagulation Factor IX Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Recombinant Human Coagulation Factor IX by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Recombinant Human Coagulation Factor IX Manufacturer Market Share in 2024
3.4.3 Top 6 Recombinant Human Coagulation Factor IX Manufacturer Market Share in 2024
3.5 Recombinant Human Coagulation Factor IX Market: Overall Company Footprint Analysis
3.5.1 Recombinant Human Coagulation Factor IX Market: Region Footprint
3.5.2 Recombinant Human Coagulation Factor IX Market: Company Product Type Footprint
3.5.3 Recombinant Human Coagulation Factor IX Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Human Coagulation Factor IX Market Size by Region
4.1.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2031)
4.1.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2031)
4.1.3 Global Recombinant Human Coagulation Factor IX Average Price by Region (2020-2031)
4.2 North America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.3 Europe Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.4 Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.5 South America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.6 Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
5.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2020-2031)
5.3 Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
6.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2020-2031)
6.3 Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
7.2 North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
7.3 North America Recombinant Human Coagulation Factor IX Market Size by Country
7.3.1 North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
7.3.2 North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
8.2 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
8.3 Europe Recombinant Human Coagulation Factor IX Market Size by Country
8.3.1 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
8.3.2 Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Recombinant Human Coagulation Factor IX Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
10.2 South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
10.3 South America Recombinant Human Coagulation Factor IX Market Size by Country
10.3.1 South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
10.3.2 South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Recombinant Human Coagulation Factor IX Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Recombinant Human Coagulation Factor IX Market Drivers
12.2 Recombinant Human Coagulation Factor IX Market Restraints
12.3 Recombinant Human Coagulation Factor IX Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Human Coagulation Factor IX and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Coagulation Factor IX
13.3 Recombinant Human Coagulation Factor IX Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human Coagulation Factor IX Typical Distributors
14.3 Recombinant Human Coagulation Factor IX Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Human Coagulation Factor IX Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 250 IU/Bottle
1.3.3 500 IU/Bottle
1.3.4 1000 IU/Bottle
1.3.5 2000 IU/Bottle
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Human Coagulation Factor IX Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Adult Patients
1.4.3 Child Patients
1.5 Global Recombinant Human Coagulation Factor IX Market Size & Forecast
1.5.1 Global Recombinant Human Coagulation Factor IX Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Recombinant Human Coagulation Factor IX Sales Quantity (2020-2031)
1.5.3 Global Recombinant Human Coagulation Factor IX Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Recombinant Human Coagulation Factor IX Product and Services
2.1.4 Grifols Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Grifols Recent Developments/Updates
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Recombinant Human Coagulation Factor IX Product and Services
2.2.4 Biogen Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Biogen Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Recombinant Human Coagulation Factor IX Product and Services
2.3.4 Octapharma Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Octapharma Recent Developments/Updates
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Recombinant Human Coagulation Factor IX Product and Services
2.4.4 Baxter Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Baxter Recent Developments/Updates
2.5 Cusabio
2.5.1 Cusabio Details
2.5.2 Cusabio Major Business
2.5.3 Cusabio Recombinant Human Coagulation Factor IX Product and Services
2.5.4 Cusabio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Cusabio Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Recombinant Human Coagulation Factor IX Product and Services
2.6.4 Sanofi Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanofi Recent Developments/Updates
2.7 Cayman
2.7.1 Cayman Details
2.7.2 Cayman Major Business
2.7.3 Cayman Recombinant Human Coagulation Factor IX Product and Services
2.7.4 Cayman Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Cayman Recent Developments/Updates
2.8 NovoPro Bioscience
2.8.1 NovoPro Bioscience Details
2.8.2 NovoPro Bioscience Major Business
2.8.3 NovoPro Bioscience Recombinant Human Coagulation Factor IX Product and Services
2.8.4 NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 NovoPro Bioscience Recent Developments/Updates
2.9 Sino Biological
2.9.1 Sino Biological Details
2.9.2 Sino Biological Major Business
2.9.3 Sino Biological Recombinant Human Coagulation Factor IX Product and Services
2.9.4 Sino Biological Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sino Biological Recent Developments/Updates
2.10 Bio-Techne
2.10.1 Bio-Techne Details
2.10.2 Bio-Techne Major Business
2.10.3 Bio-Techne Recombinant Human Coagulation Factor IX Product and Services
2.10.4 Bio-Techne Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bio-Techne Recent Developments/Updates
2.11 IDELVION
2.11.1 IDELVION Details
2.11.2 IDELVION Major Business
2.11.3 IDELVION Recombinant Human Coagulation Factor IX Product and Services
2.11.4 IDELVION Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 IDELVION Recent Developments/Updates
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Recombinant Human Coagulation Factor IX Product and Services
2.12.4 Hualan Bio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Hualan Bio Recent Developments/Updates
2.13 Shuyang
2.13.1 Shuyang Details
2.13.2 Shuyang Major Business
2.13.3 Shuyang Recombinant Human Coagulation Factor IX Product and Services
2.13.4 Shuyang Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Shuyang Recent Developments/Updates
2.14 ChinaBiologic
2.14.1 ChinaBiologic Details
2.14.2 ChinaBiologic Major Business
2.14.3 ChinaBiologic Recombinant Human Coagulation Factor IX Product and Services
2.14.4 ChinaBiologic Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 ChinaBiologic Recent Developments/Updates
2.15 Diagbio
2.15.1 Diagbio Details
2.15.2 Diagbio Major Business
2.15.3 Diagbio Recombinant Human Coagulation Factor IX Product and Services
2.15.4 Diagbio Recombinant Human Coagulation Factor IX Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Diagbio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT HUMAN COAGULATION FACTOR IX BY MANUFACTURER
3.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Manufacturer (2020-2025)
3.2 Global Recombinant Human Coagulation Factor IX Revenue by Manufacturer (2020-2025)
3.3 Global Recombinant Human Coagulation Factor IX Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Recombinant Human Coagulation Factor IX by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Recombinant Human Coagulation Factor IX Manufacturer Market Share in 2024
3.4.3 Top 6 Recombinant Human Coagulation Factor IX Manufacturer Market Share in 2024
3.5 Recombinant Human Coagulation Factor IX Market: Overall Company Footprint Analysis
3.5.1 Recombinant Human Coagulation Factor IX Market: Region Footprint
3.5.2 Recombinant Human Coagulation Factor IX Market: Company Product Type Footprint
3.5.3 Recombinant Human Coagulation Factor IX Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Human Coagulation Factor IX Market Size by Region
4.1.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2031)
4.1.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2031)
4.1.3 Global Recombinant Human Coagulation Factor IX Average Price by Region (2020-2031)
4.2 North America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.3 Europe Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.4 Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.5 South America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
4.6 Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
5.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2020-2031)
5.3 Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
6.2 Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2020-2031)
6.3 Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
7.2 North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
7.3 North America Recombinant Human Coagulation Factor IX Market Size by Country
7.3.1 North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
7.3.2 North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
8.2 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
8.3 Europe Recombinant Human Coagulation Factor IX Market Size by Country
8.3.1 Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
8.3.2 Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Recombinant Human Coagulation Factor IX Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
10.2 South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
10.3 South America Recombinant Human Coagulation Factor IX Market Size by Country
10.3.1 South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
10.3.2 South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Recombinant Human Coagulation Factor IX Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Recombinant Human Coagulation Factor IX Market Drivers
12.2 Recombinant Human Coagulation Factor IX Market Restraints
12.3 Recombinant Human Coagulation Factor IX Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Human Coagulation Factor IX and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Coagulation Factor IX
13.3 Recombinant Human Coagulation Factor IX Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human Coagulation Factor IX Typical Distributors
14.3 Recombinant Human Coagulation Factor IX Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant Human Coagulation Factor IX Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Recombinant Human Coagulation Factor IX Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Recombinant Human Coagulation Factor IX Product and Services
Table 6. Grifols Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Grifols Recent Developments/Updates
Table 8. Biogen Basic Information, Manufacturing Base and Competitors
Table 9. Biogen Major Business
Table 10. Biogen Recombinant Human Coagulation Factor IX Product and Services
Table 11. Biogen Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Biogen Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Recombinant Human Coagulation Factor IX Product and Services
Table 16. Octapharma Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Octapharma Recent Developments/Updates
Table 18. Baxter Basic Information, Manufacturing Base and Competitors
Table 19. Baxter Major Business
Table 20. Baxter Recombinant Human Coagulation Factor IX Product and Services
Table 21. Baxter Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Baxter Recent Developments/Updates
Table 23. Cusabio Basic Information, Manufacturing Base and Competitors
Table 24. Cusabio Major Business
Table 25. Cusabio Recombinant Human Coagulation Factor IX Product and Services
Table 26. Cusabio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Cusabio Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Recombinant Human Coagulation Factor IX Product and Services
Table 31. Sanofi Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Sanofi Recent Developments/Updates
Table 33. Cayman Basic Information, Manufacturing Base and Competitors
Table 34. Cayman Major Business
Table 35. Cayman Recombinant Human Coagulation Factor IX Product and Services
Table 36. Cayman Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Cayman Recent Developments/Updates
Table 38. NovoPro Bioscience Basic Information, Manufacturing Base and Competitors
Table 39. NovoPro Bioscience Major Business
Table 40. NovoPro Bioscience Recombinant Human Coagulation Factor IX Product and Services
Table 41. NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. NovoPro Bioscience Recent Developments/Updates
Table 43. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 44. Sino Biological Major Business
Table 45. Sino Biological Recombinant Human Coagulation Factor IX Product and Services
Table 46. Sino Biological Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Sino Biological Recent Developments/Updates
Table 48. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 49. Bio-Techne Major Business
Table 50. Bio-Techne Recombinant Human Coagulation Factor IX Product and Services
Table 51. Bio-Techne Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Bio-Techne Recent Developments/Updates
Table 53. IDELVION Basic Information, Manufacturing Base and Competitors
Table 54. IDELVION Major Business
Table 55. IDELVION Recombinant Human Coagulation Factor IX Product and Services
Table 56. IDELVION Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. IDELVION Recent Developments/Updates
Table 58. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 59. Hualan Bio Major Business
Table 60. Hualan Bio Recombinant Human Coagulation Factor IX Product and Services
Table 61. Hualan Bio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Hualan Bio Recent Developments/Updates
Table 63. Shuyang Basic Information, Manufacturing Base and Competitors
Table 64. Shuyang Major Business
Table 65. Shuyang Recombinant Human Coagulation Factor IX Product and Services
Table 66. Shuyang Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Shuyang Recent Developments/Updates
Table 68. ChinaBiologic Basic Information, Manufacturing Base and Competitors
Table 69. ChinaBiologic Major Business
Table 70. ChinaBiologic Recombinant Human Coagulation Factor IX Product and Services
Table 71. ChinaBiologic Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. ChinaBiologic Recent Developments/Updates
Table 73. Diagbio Basic Information, Manufacturing Base and Competitors
Table 74. Diagbio Major Business
Table 75. Diagbio Recombinant Human Coagulation Factor IX Product and Services
Table 76. Diagbio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Diagbio Recent Developments/Updates
Table 78. Global Recombinant Human Coagulation Factor IX Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 79. Global Recombinant Human Coagulation Factor IX Revenue by Manufacturer (2020-2025) & (USD Million)
Table 80. Global Recombinant Human Coagulation Factor IX Average Price by Manufacturer (2020-2025) & (US$/Dose)
Table 81. Market Position of Manufacturers in Recombinant Human Coagulation Factor IX, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 82. Head Office and Recombinant Human Coagulation Factor IX Production Site of Key Manufacturer
Table 83. Recombinant Human Coagulation Factor IX Market: Company Product Type Footprint
Table 84. Recombinant Human Coagulation Factor IX Market: Company Product Application Footprint
Table 85. Recombinant Human Coagulation Factor IX New Market Entrants and Barriers to Market Entry
Table 86. Recombinant Human Coagulation Factor IX Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 88. Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2025) & (K Dose)
Table 89. Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2026-2031) & (K Dose)
Table 90. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2025) & (USD Million)
Table 91. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2026-2031) & (USD Million)
Table 92. Global Recombinant Human Coagulation Factor IX Average Price by Region (2020-2025) & (US$/Dose)
Table 93. Global Recombinant Human Coagulation Factor IX Average Price by Region (2026-2031) & (US$/Dose)
Table 94. Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 95. Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 96. Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2020-2025) & (USD Million)
Table 97. Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2026-2031) & (USD Million)
Table 98. Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2025) & (US$/Dose)
Table 99. Global Recombinant Human Coagulation Factor IX Average Price by Type (2026-2031) & (US$/Dose)
Table 100. Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 101. Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 102. Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2025) & (US$/Dose)
Table 105. Global Recombinant Human Coagulation Factor IX Average Price by Application (2026-2031) & (US$/Dose)
Table 106. North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 107. North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 108. North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 109. North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 110. North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 111. North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 112. North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 115. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 116. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 117. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 118. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 119. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 120. Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 121. Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 123. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 124. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 125. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 126. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2025) & (K Dose)
Table 127. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2026-2031) & (K Dose)
Table 128. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2025) & (USD Million)
Table 129. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2026-2031) & (USD Million)
Table 130. South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 131. South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 132. South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 133. South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 134. South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 135. South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 136. South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 137. South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 139. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 140. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 141. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 142. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 143. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 144. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 145. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 146. Recombinant Human Coagulation Factor IX Raw Material
Table 147. Key Manufacturers of Recombinant Human Coagulation Factor IX Raw Materials
Table 148. Recombinant Human Coagulation Factor IX Typical Distributors
Table 149. Recombinant Human Coagulation Factor IX Typical Customers
Table 1. Global Recombinant Human Coagulation Factor IX Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Recombinant Human Coagulation Factor IX Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Recombinant Human Coagulation Factor IX Product and Services
Table 6. Grifols Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Grifols Recent Developments/Updates
Table 8. Biogen Basic Information, Manufacturing Base and Competitors
Table 9. Biogen Major Business
Table 10. Biogen Recombinant Human Coagulation Factor IX Product and Services
Table 11. Biogen Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Biogen Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Recombinant Human Coagulation Factor IX Product and Services
Table 16. Octapharma Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Octapharma Recent Developments/Updates
Table 18. Baxter Basic Information, Manufacturing Base and Competitors
Table 19. Baxter Major Business
Table 20. Baxter Recombinant Human Coagulation Factor IX Product and Services
Table 21. Baxter Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Baxter Recent Developments/Updates
Table 23. Cusabio Basic Information, Manufacturing Base and Competitors
Table 24. Cusabio Major Business
Table 25. Cusabio Recombinant Human Coagulation Factor IX Product and Services
Table 26. Cusabio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Cusabio Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Recombinant Human Coagulation Factor IX Product and Services
Table 31. Sanofi Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Sanofi Recent Developments/Updates
Table 33. Cayman Basic Information, Manufacturing Base and Competitors
Table 34. Cayman Major Business
Table 35. Cayman Recombinant Human Coagulation Factor IX Product and Services
Table 36. Cayman Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Cayman Recent Developments/Updates
Table 38. NovoPro Bioscience Basic Information, Manufacturing Base and Competitors
Table 39. NovoPro Bioscience Major Business
Table 40. NovoPro Bioscience Recombinant Human Coagulation Factor IX Product and Services
Table 41. NovoPro Bioscience Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. NovoPro Bioscience Recent Developments/Updates
Table 43. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 44. Sino Biological Major Business
Table 45. Sino Biological Recombinant Human Coagulation Factor IX Product and Services
Table 46. Sino Biological Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Sino Biological Recent Developments/Updates
Table 48. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 49. Bio-Techne Major Business
Table 50. Bio-Techne Recombinant Human Coagulation Factor IX Product and Services
Table 51. Bio-Techne Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Bio-Techne Recent Developments/Updates
Table 53. IDELVION Basic Information, Manufacturing Base and Competitors
Table 54. IDELVION Major Business
Table 55. IDELVION Recombinant Human Coagulation Factor IX Product and Services
Table 56. IDELVION Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. IDELVION Recent Developments/Updates
Table 58. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 59. Hualan Bio Major Business
Table 60. Hualan Bio Recombinant Human Coagulation Factor IX Product and Services
Table 61. Hualan Bio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Hualan Bio Recent Developments/Updates
Table 63. Shuyang Basic Information, Manufacturing Base and Competitors
Table 64. Shuyang Major Business
Table 65. Shuyang Recombinant Human Coagulation Factor IX Product and Services
Table 66. Shuyang Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Shuyang Recent Developments/Updates
Table 68. ChinaBiologic Basic Information, Manufacturing Base and Competitors
Table 69. ChinaBiologic Major Business
Table 70. ChinaBiologic Recombinant Human Coagulation Factor IX Product and Services
Table 71. ChinaBiologic Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. ChinaBiologic Recent Developments/Updates
Table 73. Diagbio Basic Information, Manufacturing Base and Competitors
Table 74. Diagbio Major Business
Table 75. Diagbio Recombinant Human Coagulation Factor IX Product and Services
Table 76. Diagbio Recombinant Human Coagulation Factor IX Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Diagbio Recent Developments/Updates
Table 78. Global Recombinant Human Coagulation Factor IX Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 79. Global Recombinant Human Coagulation Factor IX Revenue by Manufacturer (2020-2025) & (USD Million)
Table 80. Global Recombinant Human Coagulation Factor IX Average Price by Manufacturer (2020-2025) & (US$/Dose)
Table 81. Market Position of Manufacturers in Recombinant Human Coagulation Factor IX, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 82. Head Office and Recombinant Human Coagulation Factor IX Production Site of Key Manufacturer
Table 83. Recombinant Human Coagulation Factor IX Market: Company Product Type Footprint
Table 84. Recombinant Human Coagulation Factor IX Market: Company Product Application Footprint
Table 85. Recombinant Human Coagulation Factor IX New Market Entrants and Barriers to Market Entry
Table 86. Recombinant Human Coagulation Factor IX Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 88. Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2025) & (K Dose)
Table 89. Global Recombinant Human Coagulation Factor IX Sales Quantity by Region (2026-2031) & (K Dose)
Table 90. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2025) & (USD Million)
Table 91. Global Recombinant Human Coagulation Factor IX Consumption Value by Region (2026-2031) & (USD Million)
Table 92. Global Recombinant Human Coagulation Factor IX Average Price by Region (2020-2025) & (US$/Dose)
Table 93. Global Recombinant Human Coagulation Factor IX Average Price by Region (2026-2031) & (US$/Dose)
Table 94. Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 95. Global Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 96. Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2020-2025) & (USD Million)
Table 97. Global Recombinant Human Coagulation Factor IX Consumption Value by Type (2026-2031) & (USD Million)
Table 98. Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2025) & (US$/Dose)
Table 99. Global Recombinant Human Coagulation Factor IX Average Price by Type (2026-2031) & (US$/Dose)
Table 100. Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 101. Global Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 102. Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Global Recombinant Human Coagulation Factor IX Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2025) & (US$/Dose)
Table 105. Global Recombinant Human Coagulation Factor IX Average Price by Application (2026-2031) & (US$/Dose)
Table 106. North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 107. North America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 108. North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 109. North America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 110. North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 111. North America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 112. North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 115. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 116. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 117. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 118. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 119. Europe Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 120. Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 121. Europe Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 123. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 124. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 125. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 126. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2020-2025) & (K Dose)
Table 127. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity by Region (2026-2031) & (K Dose)
Table 128. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2020-2025) & (USD Million)
Table 129. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value by Region (2026-2031) & (USD Million)
Table 130. South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 131. South America Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 132. South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 133. South America Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 134. South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 135. South America Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 136. South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 137. South America Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2020-2025) & (K Dose)
Table 139. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Type (2026-2031) & (K Dose)
Table 140. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2020-2025) & (K Dose)
Table 141. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Application (2026-2031) & (K Dose)
Table 142. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2020-2025) & (K Dose)
Table 143. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity by Country (2026-2031) & (K Dose)
Table 144. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2020-2025) & (USD Million)
Table 145. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value by Country (2026-2031) & (USD Million)
Table 146. Recombinant Human Coagulation Factor IX Raw Material
Table 147. Key Manufacturers of Recombinant Human Coagulation Factor IX Raw Materials
Table 148. Recombinant Human Coagulation Factor IX Typical Distributors
Table 149. Recombinant Human Coagulation Factor IX Typical Customers
LIST OF FIGURES
Figure 1. Recombinant Human Coagulation Factor IX Picture
Figure 2. Global Recombinant Human Coagulation Factor IX Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type in 2024
Figure 4. 250 IU/Bottle Examples
Figure 5. 500 IU/Bottle Examples
Figure 6. 1000 IU/Bottle Examples
Figure 7. 2000 IU/Bottle Examples
Figure 8. Global Recombinant Human Coagulation Factor IX Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application in 2024
Figure 10. Adult Patients Examples
Figure 11. Child Patients Examples
Figure 12. Global Recombinant Human Coagulation Factor IX Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Recombinant Human Coagulation Factor IX Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Recombinant Human Coagulation Factor IX Sales Quantity (2020-2031) & (K Dose)
Figure 15. Global Recombinant Human Coagulation Factor IX Price (2020-2031) & (US$/Dose)
Figure 16. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Recombinant Human Coagulation Factor IX by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Recombinant Human Coagulation Factor IX Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Recombinant Human Coagulation Factor IX Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Recombinant Human Coagulation Factor IX Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Recombinant Human Coagulation Factor IX Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2031) & (US$/Dose)
Figure 31. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2020-2031)
Figure 33. Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2031) & (US$/Dose)
Figure 34. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 46. France Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value Market Share by Region (2020-2031)
Figure 54. China Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 57. India Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 74. Recombinant Human Coagulation Factor IX Market Drivers
Figure 75. Recombinant Human Coagulation Factor IX Market Restraints
Figure 76. Recombinant Human Coagulation Factor IX Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant Human Coagulation Factor IX in 2024
Figure 79. Manufacturing Process Analysis of Recombinant Human Coagulation Factor IX
Figure 80. Recombinant Human Coagulation Factor IX Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Recombinant Human Coagulation Factor IX Picture
Figure 2. Global Recombinant Human Coagulation Factor IX Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Type in 2024
Figure 4. 250 IU/Bottle Examples
Figure 5. 500 IU/Bottle Examples
Figure 6. 1000 IU/Bottle Examples
Figure 7. 2000 IU/Bottle Examples
Figure 8. Global Recombinant Human Coagulation Factor IX Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application in 2024
Figure 10. Adult Patients Examples
Figure 11. Child Patients Examples
Figure 12. Global Recombinant Human Coagulation Factor IX Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Recombinant Human Coagulation Factor IX Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Recombinant Human Coagulation Factor IX Sales Quantity (2020-2031) & (K Dose)
Figure 15. Global Recombinant Human Coagulation Factor IX Price (2020-2031) & (US$/Dose)
Figure 16. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Recombinant Human Coagulation Factor IX by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Recombinant Human Coagulation Factor IX Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Recombinant Human Coagulation Factor IX Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Recombinant Human Coagulation Factor IX Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Recombinant Human Coagulation Factor IX Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Recombinant Human Coagulation Factor IX Average Price by Type (2020-2031) & (US$/Dose)
Figure 31. Global Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Recombinant Human Coagulation Factor IX Revenue Market Share by Application (2020-2031)
Figure 33. Global Recombinant Human Coagulation Factor IX Average Price by Application (2020-2031) & (US$/Dose)
Figure 34. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 46. France Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Recombinant Human Coagulation Factor IX Consumption Value Market Share by Region (2020-2031)
Figure 54. China Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 57. India Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Recombinant Human Coagulation Factor IX Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Recombinant Human Coagulation Factor IX Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Recombinant Human Coagulation Factor IX Consumption Value (2020-2031) & (USD Million)
Figure 74. Recombinant Human Coagulation Factor IX Market Drivers
Figure 75. Recombinant Human Coagulation Factor IX Market Restraints
Figure 76. Recombinant Human Coagulation Factor IX Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant Human Coagulation Factor IX in 2024
Figure 79. Manufacturing Process Analysis of Recombinant Human Coagulation Factor IX
Figure 80. Recombinant Human Coagulation Factor IX Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
